These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

773 related items for PubMed ID: 17207944

  • 1. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A, Siegel SJ, Winey KI.
    Int J Pharm; 2007 May 24; 336(2):367-75. PubMed ID: 17207944
    [Abstract] [Full Text] [Related]

  • 2. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.
    Nanomedicine; 2007 Dec 24; 3(4):246-57. PubMed ID: 18068091
    [Abstract] [Full Text] [Related]

  • 3. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S, Mukherjee S, Ray S, Thakur RS, Ghosh LK, Gupta BK.
    Pak J Pharm Sci; 2007 Apr 24; 20(2):157-62. PubMed ID: 17416573
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V, Sadoqi M, Shao J.
    Int J Pharm; 2004 Jul 08; 278(2):293-301. PubMed ID: 15196634
    [Abstract] [Full Text] [Related]

  • 6. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH, Park TG.
    Int J Pharm; 2006 Mar 27; 311(1-2):223-8. PubMed ID: 16423477
    [Abstract] [Full Text] [Related]

  • 7. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM.
    J Control Release; 2008 Feb 11; 125(3):193-209. PubMed ID: 18083265
    [Abstract] [Full Text] [Related]

  • 8. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F, Hosseini-Nasr M, Rad-Malekshahi M, Samadi N, Atyabi F, Dinarvand R.
    Nanomedicine; 2007 Jun 11; 3(2):161-7. PubMed ID: 17468055
    [Abstract] [Full Text] [Related]

  • 9. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X, Zou W, Liu C, Zhang N, Fu C.
    Drug Dev Ind Pharm; 2009 Nov 11; 35(11):1375-83. PubMed ID: 19832638
    [Abstract] [Full Text] [Related]

  • 10. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H, Chen S, Osamuyimen AA, Cevher E, Oya Alpar H.
    J Microencapsul; 2008 Dec 11; 25(8):541-8. PubMed ID: 18465303
    [Abstract] [Full Text] [Related]

  • 11. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC.
    J Biomater Appl; 2008 Jan 11; 22(4):353-71. PubMed ID: 17494965
    [Abstract] [Full Text] [Related]

  • 12. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
    Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN.
    J Control Release; 2007 May 14; 119(1):77-85. PubMed ID: 17349712
    [Abstract] [Full Text] [Related]

  • 13. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM, Domínguez-Delgado CL, Escobar-Chávez JJ, Leyva-Gómez G, Ganem-Quintanar A, Quintanar-Guerrero D.
    Int J Pharm; 2009 Apr 17; 371(1-2):177-81. PubMed ID: 19150491
    [Abstract] [Full Text] [Related]

  • 14. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
    Cohen-Sela E, Chorny M, Koroukhov N, Danenberg HD, Golomb G.
    J Control Release; 2009 Jan 19; 133(2):90-5. PubMed ID: 18848962
    [Abstract] [Full Text] [Related]

  • 15. Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study.
    Vandervoort J, Ludwig A.
    Pharmazie; 2001 Jun 19; 56(6):484-8. PubMed ID: 11446170
    [Abstract] [Full Text] [Related]

  • 16. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T.
    Eur J Pharm Biopharm; 2008 Feb 19; 68(2):214-23. PubMed ID: 17651954
    [Abstract] [Full Text] [Related]

  • 17. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles.
    Ozturk K, Caban S, Kozlu S, Kadayifci E, Yerlikaya F, Capan Y.
    Pharmazie; 2010 Sep 19; 65(9):665-9. PubMed ID: 21038843
    [Abstract] [Full Text] [Related]

  • 18. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles.
    Budhian A, Siegel SJ, Winey KI.
    Int J Pharm; 2008 Jan 04; 346(1-2):151-9. PubMed ID: 17681683
    [Abstract] [Full Text] [Related]

  • 19. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.
    Mainardes RM, Evangelista RC.
    Int J Pharm; 2005 Feb 16; 290(1-2):137-44. PubMed ID: 15664139
    [Abstract] [Full Text] [Related]

  • 20. Novel one-pot facile technique for preparing nanoparticles modified with hydrophilic polymers on the surface via block polymer-assisted emulsification/evaporation process.
    Kanakubo Y, Ito F, Murakami Y.
    Colloids Surf B Biointerfaces; 2010 Jun 15; 78(1):85-91. PubMed ID: 20223642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.